Wikipedia -WSS

Wikipedia

author：focus 2025-09-06 04:14:05 - browse：13

Mathai Mammen crosses his arms and looks into the camera — coverage from STAT — FogPharma CEO Mathai Mammen Boston Globe Photo Import

Oncology startup FogPharma just closed a $145 million Series E round, the company confirmed, reaching a late stage of financing that few other biotechs have hit in recent years.

FogPharma, which is headquartered in Cambridge, Mass., is developing cancer treatments using corkscrew-shaped peptides called helicons that could possibly better breach cells.

As CEO Mathai Mammen sees it, very few exemplary medicines shuttle off of drug companies’ pipelines, wade through clinical trials, and end up in the hands of physicians and patients in a given year. Far more often, pharma and biotech companies are pushing out drugs that are incrementally better than what came before, extending cancer patients’ survival by a few more months, halting their tumor growth for a little while longer. But FogPharma could deliver something truly unique, Mammen said.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： BioMarin wins approval for gene therapy to treat hemophilia A
Next article： Medical mystery: When an infection after surgery isn’t what it seems

explore

WSS

UHS says company favors patients whose insurance pays more

Russian court extends detention of American musician

The battle over 'scope creep' and who gets to be called 'doctor'

STAT Report: Patient voices and perspectives

What to watch for from Zogenix and Amicus clinical trials

Russian court extends detention of American musician

leisure time

Wikipedia

hotspot

Psychedelics group wrestles with new pharma identity

Search called off for baby washed away in Pennsylvania flash flood

New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum

Dems pitch expanding Medicare power to negotiate drug prices

What does generative AI mean for health care? We asked experts

CDC Director Mandy Cohen on transparency, trust, and health

In age of alternative facts, a scholarly course on calling out crap

Search called off for baby washed away in Pennsylvania flash flood

Apple is now the first public company to be valued at $3 trillion

Slain Parkland victim's father speaks out following reenactment

leisure time

Medical mystery: When an infection after surgery isn’t what it seems

Biogen says it will cut costs by $700 million, slash 1,000 jobs

Dems pitch expanding Medicare power to negotiate drug prices

Russian court extends detention of American musician

What it's like to live with paralysis for one psychologist

'Investigate these claims': UFO transparency at center of House hearing

explore

hotspot

explore

entertainment